8/10/2004

Researchers report the first-ever trial on an allergy vaccine developed from genetically engineered pollen shows promise in treating the condition by triggering a strong immune response in the body. The vaccine is seen as a replacement for immunotherapy, a common treatment for allergies that sometimes can make the problem worse.

Full Story:
Forbes

Related Summaries